| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 06/22/2006 | CA2588389A1 Substituted phenols as active agents inhibiting vegf production |
| 06/21/2006 | EP1671949A2 Substituted phenylamines and pyridinylamines |
| 06/21/2006 | EP1671948A1 Cinnamoyl compound and use of the same |
| 06/21/2006 | EP1670775A1 Piperazine subtituted compounds used as calcium channel blockers |
| 06/21/2006 | EP1670761A1 Tetrahydro-naphthalene and urea derivatives |
| 06/21/2006 | EP1670760A1 Organic compounds |
| 06/21/2006 | EP1670739A2 Cyclic diamines and derivatives as factor xa inhibitors |
| 06/21/2006 | EP1539160B1 Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders |
| 06/21/2006 | EP1049662B1 Inhibitors of alpha4 mediated cell adhesion |
| 06/21/2006 | CN1791592A 免疫抑制剂化合物和组合物 Immunosuppressant compounds and compositions |
| 06/21/2006 | CN1791579A Novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same |
| 06/21/2006 | CN1791578A Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists |
| 06/21/2006 | CN1791568A Hsp90 family protein inhibitors |
| 06/21/2006 | CN1791395A 免疫抑制剂化合物及组合物 Immunosuppressant compounds and compositions |
| 06/21/2006 | CN1789263A Substituted piperazidine-piperidine amide compound, preparation method and uses thereof |
| 06/21/2006 | CN1789262A Improvement of preparation of Naratriptan |
| 06/21/2006 | CN1789249A Hindered amine group-containing substituted benzamide intermediate compound and preparation method thereof |
| 06/21/2006 | CN1789248A Hindered amine group-containing substituted benzoate intermediate compound and preparation method thereof |
| 06/21/2006 | CN1789247A Method for preparing chiral disubstituted or alpha, alpha'-double instituted N-acylpyrrolidine or N-acylpiperidine |
| 06/20/2006 | US7064211 Hemiasterlin derivatives and uses thereof |
| 06/20/2006 | US7064210 Light resistant colorant and composition containing the same |
| 06/20/2006 | US7064138 Also treating bulimia nervosa, irritable bowel syndrome, urinary incontinence, asthma, bradycardia, and bradyarrhythmia |
| 06/20/2006 | US7064137 Analgesics; anxiolytic agents; gastrointestinal disorders |
| 06/20/2006 | US7064136 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents |
| 06/20/2006 | US7064135 Antihistamines; anticholesterol agents; cardiovascular disorders; antidiabetic agents; anticancer agents |
| 06/20/2006 | US7064128 Preferentially substituted calcium channel blockers |
| 06/15/2006 | WO2006063025A1 Stable non-crystalline formulation comprising donepezil |
| 06/15/2006 | WO2006062093A1 Novel anthranilic acid derivative or salt thereof |
| 06/15/2006 | WO2006062063A1 Piperidine derivative and process for producing the same |
| 06/15/2006 | WO2006018222A8 Hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl) benzamide, methods for the production thereof, and use thereof as medicaments |
| 06/15/2006 | WO2006017045A3 Formation of tetra-substituted enamides and stereoselective reduction thereof |
| 06/15/2006 | WO2006003494A3 Piperidine derivatives and their use as insecticides, acaricides, molluscicides or nematicides |
| 06/15/2006 | WO2005122698A3 Novel stable polymorphic forms of tiagabine hydrochloride |
| 06/15/2006 | US20060128973 N-[4-[(1E)-3-amino-1-propenyl]phenyl]-4'-(trifluoromethyl)-[1,1'-biphenyl]-2-carboxamide; for treatment of hyperlipidemia, obesity and type II diabetes |
| 06/15/2006 | US20060128972 N-(p-(2-alpha-carboxybenzylamino)ethylamino)phenyl)p-(p-trifluoromethylphenyl)benzamide; antiobesity and anti-type II diabetic agents |
| 06/15/2006 | US20060128963 Piperidine derivatives as melanocortin-4 receptor agonists |
| 06/15/2006 | US20060128957 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 06/15/2006 | US20060128903 Process for the controlled increase in the molecular weight of polyethylenes |
| 06/15/2006 | US20060128763 Stable amorphous amlodipine camsylate, process for preparing same and composition for oral administration thereof |
| 06/15/2006 | US20060128753 4-Aminopiperidine derivatives, processes for their preparation and their use as medicaments |
| 06/15/2006 | US20060128752 Chemical compounds |
| 06/15/2006 | US20060128704 2-Hydroxy-1,2,3,4-tetrahydronaphthalenes substituted in the 8-position with a biphenylcarbonylamino-, biphenylcarbonylaminoalkyl-, biphenylaminocarbonylamino-, or biphenylaminocarbonylaminoalkyl- group; vanilloid receptor antagonists |
| 06/15/2006 | CA2588633A1 Novel anthranilic acid derivative or salt thereof |
| 06/15/2006 | CA2587749A1 Piperidine derivative and process for producing the same |
| 06/14/2006 | EP1669357A1 SUBSTANCE WHICH EXHIBITS ANTIVIRAL AND ANTIBACTERIAL ACTIVITY AND IS BASED ON DERIVATIVES OF 2,8-DITHIOXO-1H-PYRANO 2,3D&cedi l;6,5-D DIPYRIMIDYNE AND 10-AZA-ANALOGUE THEREOF |
| 06/14/2006 | EP1669350A1 Novel piperidine derivative |
| 06/14/2006 | EP1669349A1 New crystalline forms of donepezil base |
| 06/14/2006 | EP1668008A2 Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use |
| 06/14/2006 | EP1667972A2 Diastereomers of 4-aryloxy-3-hydroxypiperidines |
| 06/14/2006 | EP1667971A1 Fexofenadine polymorphs and processes of preparing the same |
| 06/14/2006 | EP1667955A2 Cycloalkylidene compounds as modulators of the estrogen receptor |
| 06/14/2006 | EP1667643A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 06/14/2006 | EP1362083B1 Ink-jet ink and recording material |
| 06/14/2006 | CN1787997A 4-arylsulphonylpiperidine derivatives for antagonism of the 5-HT2A receptor |
| 06/14/2006 | CN1787996A Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
| 06/14/2006 | CN1787995A Alpha, omega-dicarboximide derivatives as useful uro-selective alpha1alpha adrenoceptor blockers |
| 06/14/2006 | CN1787989A Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 06/14/2006 | CN1787818A Amino cyclobutylamide modulators of chemokine receptor activity |
| 06/14/2006 | CN1787817A 免疫抑制剂化合物及组合物 Immunosuppressant compounds and compositions |
| 06/13/2006 | USRE39128 Antibacteria drug; respiratory system disorders; otitis |
| 06/13/2006 | US7060850 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 06/13/2006 | US7060838 Industrial process for the synthesis of isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridine dicarboxylate (nisoldipine) |
| 06/13/2006 | US7060836 Lactams as tachykinin antagonists |
| 06/13/2006 | US7060717 Phosphodiesterase inhibitor; antiinflammatory agents; antiallergens; respiratory system disorders; wound healing agents |
| 06/13/2006 | US7060715 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 06/13/2006 | US7060713 Substituted piperidines |
| 06/13/2006 | US7060702 Chemical compounds |
| 06/13/2006 | US7060697 Immunosuppressant compounds and compositions |
| 06/13/2006 | CA2433288C Process for making amlodipine maleate |
| 06/13/2006 | CA2156764C Process for the preparation of the (-)-n-methyl-n-[4-(4-phenyl-4-acetylaminopiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]benzamine and its pharmaceutically acceptable salts |
| 06/08/2006 | WO2006060810A1 Sulfonamide compounds as cysteine protease inhibitors |
| 06/08/2006 | WO2006060225A2 Process for asymmetric synthesis of hexahydropyrimido[1,2-a] azepine-2-carboxamides and related compounds |
| 06/08/2006 | WO2006060109A1 2-aminopyridine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/08/2006 | WO2006059886A1 Optical resolution method of amlodipine |
| 06/08/2006 | WO2006059332A1 Intermediates for the preparation of lercanidipine |
| 06/08/2006 | WO2006058700A1 Acetamide compounds as fungicides |
| 06/08/2006 | WO2006043148B1 Process for producing enantiomer of amlodipine in high optical purity |
| 06/08/2006 | WO2006026533A3 Methods of treatment of amyloidosis using ethanol cyclicamine derivatives aspartyl protease inhibitors |
| 06/08/2006 | WO2006021656A3 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists |
| 06/08/2006 | WO2005107464A3 Compounds and compositions as cathepsin s inhibitors |
| 06/08/2006 | WO2005076749A3 A novel process for the preparation of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine |
| 06/08/2006 | US20060122432 Aryl piperidine derivatives and use thereof to reduce elevated levels of ldl-cholesterol |
| 06/08/2006 | US20060122268 Such as N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-(4' -(methylsulfonyl)-1,1'-biphenyl-4-yl) ethyl)-L-leucinamide; for treating osteoporosis and other bone loss disorders |
| 06/08/2006 | US20060122227 Process for alkylating secondary amines and the use in donepezil preparation thereof |
| 06/08/2006 | US20060122226 Crystalline forms of Donepezil base |
| 06/08/2006 | US20060122166 Chemokine receptors; inhibition of HIV replication; acquired immune deficiency syndrome (AIDS); cis N-(4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-4-phenylcyclohexyl)-1H-pyrazole-4-carboxamide |
| 06/08/2006 | CA2589099A1 Optical resolution method of amlodipine |
| 06/08/2006 | CA2588466A1 Use of atazanavir for improving the pharmacokinetics of drugs metabolized by ugt1a1 |
| 06/08/2006 | CA2585279A1 2-aminopyridine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/07/2006 | EP1666481A2 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors |
| 06/07/2006 | EP1666466A2 Mutilin derivatives and their use as Antimicrobials |
| 06/07/2006 | EP1666465A1 Composition comprising a tachykinin receptor antagonist and a selective serotonin reuptake inhibitor |
| 06/07/2006 | EP1666464A1 Piperidine derivative having nmda receptor antagonistic activity |
| 06/07/2006 | EP1664088A2 Hemiasterlin derivatives and uses thereof |
| 06/07/2006 | EP1664010A1 Sulfonamides antagonising n-type calcium channels |
| 06/07/2006 | EP1663975A1 Novel gamma secretase inhibitors |
| 06/07/2006 | EP1663972A1 The claimed invention relates to novel 4-piperidinecarboxamide and the use thereof for the preparation of medicaments against 5-ht2a receptor-related disorders |
| 06/07/2006 | EP1663971A1 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists |
| 06/07/2006 | EP1663960A2 Amidines and derivatives thereof and pharmaceutical compositions containing them |
| 06/07/2006 | EP1663958A2 Haloalkyl containing compounds as cysteine protease inhibitors |